BF 2 ‐Bridged Azafulvene Dimer‐Based 1064 nm Laser‐Driven Superior Photothermal Agent for Deep‐Seated Tumor Therapy
Angewandte Chemie International Edition · 19.08.2024 · 63 (34)
DOI: 10.1002/anie.202407307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 24.07.2024. Verfasst von Mingwang Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life…. Hauptthemen laut MEDLINE: Boron Compounds, Photothermal Therapy, Lasers. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Binhai Laboratory, Research Grants Council of Hong Kong.
Abstract (Originalsprache)
Small organic photothermal agents (PTAs) with absorption bands located in the second near‐infrared (NIR‐II, 1000–1700 nm) window are highly desirable for effectively combating deep‐seated tumors. However, the rarely reported NIR‐II absorbing PTAs still suffer from a low molar extinction coefficient (MEC, ϵ ), inadequate chemostability and photostability, as well as the high light power density required during the therapeutic process. Herein, we developed a series of boron difluoride bridged azafulvene dimer acceptor‐integrated small organic PTAs. The B‐N coordination bonds in the π‐conjugated azafulvene dimer backbone endow it the strong electron‐withdrawing ability, facilitating the vigorous donor‐acceptor‐donor (D‐A‐D) structure PTAs with NIR‐II absorption. Notably, the PTA namely OTTBF shows high MEC (7.21×10 4 M −1 cm −1 ), ultrahigh chemo‐ and photo‐stability. After encapsulated into water‐dispersible nanoparticles, OTTBF NPs can achieve remarkable photothermal conversion effect under 1064 nm irradiation with a light density as low as 0.7 W cm −2 , which is the lowest reported NIR‐II light power used in PTT process as we know. Furthermore, OTTBF NPs have been successfully applied for in vitro and in vivo deep‐seated cancer treatments under 1064 nm laser. This study provides an insight into the future exploration of versatile D‐A‐D structured NIR‐II absorption organic PTAs for biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life Science, State Key Laboratory of Molecular Neuroscience, and Departme…
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian, 116024, China.
- Clinical Translational Research Center of Aggregation-Induced Emission, The Second Affiliated Hospital, School of Medicine, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The…
ORCID-Profile: Ben Zhong Tang
Förderung
- National Natural Science Foundation of China
- Liaoning Binhai Laboratory
- Research Grants Council of Hong Kong
- Innovation and Technology Commission
- National Key Research and Development Program of China
- Shenzhen Key Laboratory of Functional Aggregate Materials
- Science Technology Innovation Commission of Shenzhen Municipality
Zitieren
APA
Yang, M., Ou, X., Li, J., Sun, J., Zhao, Z., Lam, J. W. Y., Fan, J., & Tang, B. Z. (2024). BF 2 ‐Bridged Azafulvene Dimer‐Based 1064 nm Laser‐Driven Superior Photothermal Agent for Deep‐Seated Tumor Therapy. Angewandte Chemie International Edition, 63(34). https://doi.org/10.1002/anie.202407307
Vancouver
Yang M, Ou X, Li J, Sun J, Zhao Z, Lam JWY, et al. BF 2 ‐Bridged Azafulvene Dimer‐Based 1064 nm Laser‐Driven Superior Photothermal Agent for Deep‐Seated Tumor Therapy. Angewandte Chemie International Edition. 2024;63(34). doi:10.1002/anie.202407307
BibTeX
@article{Yang2024,
author = {Yang, Mingwang and Ou, Xinwen and Li, Jianwei and Sun, Jianwei and Zhao, Zheng and Lam, Jacky W Y and Fan, Jiangli and Tang, Ben Zhong},
title = {BF 2 ‐Bridged Azafulvene Dimer‐Based 1064 nm Laser‐Driven Superior Photothermal Agent for Deep‐Seated Tumor Therapy},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {34},
doi = {10.1002/anie.202407307}
}
EUVIMED